-
公开(公告)号:ZA895176B
公开(公告)日:1990-03-28
申请号:ZA895176
申请日:1989-07-07
Applicant: HOECHST AG
Inventor: KLOSA JOSEF , JOSEF KLOSA , KROEGER HANS , HANS KROEGER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER , WINKLER IRVIN , IRVIN WINKLER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , SCHRINNER ELMAR , ELMAR SCHRINNER
IPC: A61K31/52 , A61P31/12 , C07D473/38 , C07D
-
公开(公告)号:ZA9102015B
公开(公告)日:1991-12-24
申请号:ZA9102015
申请日:1991-03-19
Applicant: HOECHST AG
Inventor: JAEHNE GERHARD , GERHARD JAEHNE , ROESNER MANFRED , MANFRED ROESNER , WINKLER IRVIN , IRVIN WINKLER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , SCHOLL THOMAS , THOMAS SCHOLL
IPC: A61K31/52 , A61K31/522 , A61P31/12 , A61P31/22 , C07D473/00 , C07D473/04 , C07D473/16 , C07D473/18 , C07D473/20 , C07D473/22 , C07D473/24 , C07D473/28 , C07D473/32 , C07D473/34 , C07D473/36 , C07D473/40 , C07D , A61K
CPC classification number: C07D473/04 , C07D473/16 , C07D473/18 , C07D473/24 , C07D473/32 , C07D473/40
-
公开(公告)号:ZA9010269B
公开(公告)日:1991-09-25
申请号:ZA9010269
申请日:1990-12-20
Applicant: HOECHST AG
Inventor: PEYMAN ANUSCHIRWAN , ANUSCHIRWAN PEYMAN , UHLMANN EUGEN , EUGEN UHLMANN , WINKLER IRVIN , IRVIN WINKLER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: A61K31/66 , A61K31/662 , A61K31/675 , A61K31/685 , A61P31/12 , A61P31/18 , C07F9/38 , C07F9/40 , C07F9/58 , C07F9/653 , C07F9/6539 , C07F9/6558 , C07F9/6571 , C07F , A61K
Abstract: The compound of the formula I in which R represents an aldehyde group or a group which can be converted into an aldehyde, R and R represent alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, hydrogen, sodium, potassium, calcium, magnesium, aluminium, lithium, ammonium or triethylammonium or R and R together form a cyclic diester, R and R represent alkyl, alkenyl, alkynyl, cycloalkyl, hydrogen, alkoxy or halogen, R and R represent alkyl, alkenyl, alkynyl, aralkyl, cycloalkyl, alkoxy, phenyl, cyanide, hydroxyl or hydrogen, X, Y or Z represent oxygen or sulphur, or prodrug forms of the compound of the formula I can be used for treatment of diseases caused by viruses. The preparation of these compounds and pharmaceutical preparations which contain them and also their use are described.
-
公开(公告)号:MA22839A1
公开(公告)日:1993-10-01
申请号:MA23133
申请日:1993-03-23
Applicant: HOECHST AG
Inventor: GERHARD JAHNE , IRVIN WINKLER , MATTHIAS HELSBERG , GERHARD GROSS , THOMAS SCHOLL
IPC: A61K31/52 , A61P31/12 , C07D473/00 , C07D473/32
-
5.
公开(公告)号:AU3191193A
公开(公告)日:1993-07-29
申请号:AU3191193
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: EUGEN UHLMANN , ANUSCHIRWAN PEYMAN , GERARD O'MALLEY , MATTHIAS HELSBERG , IRVIN WINKLER
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/24 , C07F9/44 , C07H21/00 , C07H21/04 , C12Q1/68
Abstract: Oligonucleotide analogs (I) and their physiologically tolerable salts. Oligonucleotide analogs and their physiologically tolerable salts of formula (I) are new. R = H, a substituent or -P(=W)ZZ'; R = H, OH, 1-18C alkoxy, halo, azido or amino; B = nucleotide base residue; A = oxy or methylene; d, e, f = 0-50; i = 1-10; r = 0 or 1; W = oxo, selenoxo or thioxo; V = oxy, sulfandiyl or imino; Y = oxy, sulfandiyl, imino or methylene; Y' = oxy, sulfandiyl, imino, (CH2)m or V(CH2)m; m = 1-18; X = OH or SH; U, R , R = substituents; p = 1-100; q = 0-18; R = H or functional group; Sp = a (3',5'-) spacer group of formula (i); g, g' = 0 or 1; h = 0-10; G = 1-12C alkylene (optionally substituted), (6-14C)aryldi-(1-8C)alkylene, 6-18C arylene, (CH2CH2V) alpha CH2CH2, (CH2V) alpha CH2, -(G-Y-P(=W)(U)-Y'-) beta or a group of formula (ii); alpha = 1-11; beta = 1-6; Z, Z' = OH, (seleno)thio or a substituent; provided that r is 0 when V is Y' and is 1 if i is greater than 1. Positions of R and the adjacent phosphoryl residue can be reversed; each nucleoside had D- or L-configuration and each B has alpha or beta configuration. Independent claims are also included for: (1) a method for producing (I); (2) the phosphitylation reagent of formula DMTr-X'-G'-Y''-P(U')(NR R ); and (3) a pharmaceutical composition containing at least one compound (I) and optionally auxiliary, carrier and/or other active agents. R , R = 1-12C alkyl or together form a 5-6 membered ring; DMTr = dimethoxytrityl; X', Y'' = oxy or sulfandiyl; U' = 1-4C alkyl or protected OH; G' = (CH2CH2O) alpha CH2CH2 or CH2CH(OR')CH2; and R' = 1-18C alkyl, 6-14C aryl or 6-14C aryl(1-8C) alkyl.
-
公开(公告)号:AU3191093A
公开(公告)日:1993-07-29
申请号:AU3191093
申请日:1993-01-21
Applicant: HOECHST AG
Inventor: EUGEN UHLMANN , ANUSCHIRWAN PEYMAN , GERARD O'MALLEY , MATTHIAS HELSBERG , IRVIN WINKLER
IPC: A61K31/70 , A61K31/7125 , A61K48/00 , A61P31/12 , A61P35/00 , C07F9/22 , C07F9/24 , C07H1/00 , C07H21/00 , C07H21/04 , C12Q1/68
Abstract: The invention relates to compounds of the formula I in which R is H, alkyl, acyl, aryl or a phosphate residue; R is H, OH, alkoxy, NH2 or halogen; B is a base customary in nucleotide chemistry; a is O or CH2; n is an integer from 1 to 100; W is O, S or Se; V is O, S or NH; Y is O, S, NH or CH2; Y' is O, S, NH or alkylene; X is OH or SH; U is OH, SH, SeH, alkyl, aryl or amine, and Z is OH, SH, SeH, an optionally substituted radical from the series comprising alkyl, aryl, heteroaryl, alkoxy or amino or a group which favours intracellular uptake or as labelling of a DNA probe or which on hybridisation interacts with the target nucleic acid, where if Z is OH, SH, CH3 or OC2H5, at least one of the groups X, Y, Y', V, W is not equal to OH or O, or R is not equal to H; process for their preparation and their use as inhibitors of gene expression, as probes for detecting nucleic acids and as aids in molecular biology.
-
公开(公告)号:ZA885577B
公开(公告)日:1989-04-26
申请号:ZA885577
申请日:1988-07-29
Applicant: HOECHST AG
Inventor: SCHRINNER ELMAR , ELMAR SCHRINNER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , WINKLER IRVIN , IRVIN WINKLER , MEICHSNER CHRISTOPH , CHRISTOPH MEICHSNER
IPC: C07D473/06 , A61K20060101 , A61K31/52 , A61K31/70 , A61K31/715 , A61P31/12 , C07D20060101 , C07D473/04 , C08B20060101 , C08B37/00 , A61K , C08B , C07D
Abstract: The preparation contains or consists of… a) at least one sulphated polysaccharide and… b) at least one xanthine derivative. The preparation is suitable for the control and prophylaxis of viral diseases, especially those caused by retroviruses.
-
公开(公告)号:ZA912015B
公开(公告)日:1991-12-24
申请号:ZA912015
申请日:1991-03-19
Applicant: HOECHST AG
Inventor: JAEHNE GERHARD , GERHARD JAEHNE , ROESNER MANFRED , MANFRED ROESNER , WINKLER IRVIN , IRVIN WINKLER , HELSBERG MATTHIAS , MATTHIAS HELSBERG , SCHOLL THOMAS , THOMAS SCHOLL
IPC: A61K31/52 , A61K31/522 , A61P31/12 , A61P31/22 , C07D473/00 , C07D473/04 , C07D473/16 , C07D473/18 , C07D473/20 , C07D473/22 , C07D473/24 , C07D473/28 , C07D473/32 , C07D473/34 , C07D473/36 , C07D473/40 , C07D , A61K
Abstract: Purine derivs. of formula (I) and their salts are new. R1 = H, halo, NH3, OH, 1-6C alkoxy, -O-CH2Ph, -OPh, SH, 1-6C alkylthio, -S-CH2Ph, -SPh, NH2, 1-6C alkylamino, -NH-CH2Ph, -NH-Ph, 2-12C dialkylamino, -N(CH2Ph)2, cyclic dialkylamino, -N(Ph)2, 1-8C acylamino, 2-16C diacylamino, (N-alkyl-2-pyrrolidin-yliden)amino or 2-10C dialkylaminomethylidenamino; R2 = H, halo, N3, OH, SH, NH2, 1-6C alkylamino, 2-12C dialkylamino, -NH-CH2Ph, -N-(CH2Ph)2, cyclic dialkylamino, -NH-Ph, -N(Ph)2, 1-8C acylamino or thioacylamino, 2-16C diacylamino or di(thioacyl)amino; R3 = H, 1-6C alkyl (opt. substd.) or R8, where R8 is a phosphate ester-contg. gp.; R4 = H, 1-6C alkyl, OH, SH, NH2, halo, N3, 1-6C alkoxy, alkylthio or alkylamino, 2-12C dialkylamino, -O-CH2Ph, -S-CH2Ph, -NH-CH2Ph, -N(CH2Ph)2, -NHPh, -N(Ph)2, -OPh, -SPh, 1-8C acyloxy, 1-8C acylthio, 1-8C acylamino, 2-16C diacylamino, -O-(1-4C alkyl)-P(O)(OR6)(OR7) or -O(1-4C alkyl)-P(1-6C alkyl)(=O)(OR6); R5 = H, 1-6C alkyl (opt. substd.). A number of provisos are given in the specification.
-
公开(公告)号:ZA91762B
公开(公告)日:1991-10-30
申请号:ZA91762
申请日:1991-02-01
Applicant: HOECHST AG
Inventor: BUDT KARLHEINZ , WINKLER IRVIN , KARLHEINZ BUDT , IRVIN WINKLER , ANUSCHIRWAN REYMAN , UHLMANN EUGEN , EUGEN UHLMANN , KNOLLE JOCHEN , REYMAN ANUSCHIRWAN , HELSBERG MATTHIAS , JOCHEN KNOLLE , MATTHIAS HELSBERG
Abstract: The use of a compound of the formula I I in which V is an alkyl group, fluorine, chlorine, bromine, or iodine, n is an integer from 1 to 5, W is an alkyl, alkenyl, alkynyl or alkoxy group, cyanide, nitro, carboxyl, hydrogen or a cycloalkyl, aryl, aralkyl or carboalkoxy group, R1 and R2 are an alkyl, alkenyl, alkynyl, cycloalkyl or halogenoalkyl group, sodium, potassium, calcium, magnesium, aluminum, lithium, ammonium, triethylammonium or hydrogen, R1 and R2 together form a cyclic diester, R3 and R4 are an alkyl, alkenyl, alkynyl, carboalkoxy, cycloalkyl or alkoxy group, hydrogen, fluorine, chlorine, bromine or iodine and X, Y and Z are oxygen or sulfur, for the treatment of diseases caused by DNA viruses or RNA viruses is described.
-
10.
公开(公告)号:ZA9100762B
公开(公告)日:1991-10-30
申请号:ZA9100762
申请日:1991-02-01
Applicant: HOECHST AG
Inventor: REYMAN ANUSCHIRWAN , ANUSCHIRWAN REYMAN , BUDT KARLHEINZ , KARLHEINZ BUDT , WINKLER IRVIN , IRVIN WINKLER , UHLMANN EUGEN , EUGEN UHLMANN , KNOLLE JOCHEN , JOCHEN KNOLLE , HELSBERG MATTHIAS , MATTHIAS HELSBERG
CPC classification number: C07F9/65742 , C07F9/3882 , C07F9/4056
-
-
-
-
-
-
-
-
-